The primary objective of the study is to evaluate the long-term safety of fluticasone
propionate inhalation powder in 2 strengths and fluticasone propionate/salmeterol inhalation
powder in 2 strengths when administered with the Teva MDPI device over 26 weeks in patients
with persistent asthma
Minimum age: 12 Years.
Maximum age: N/A.
Gender(s): Both.
Teva Investigational Site 12068, Birmingham, Alabama, United States
Teva Investigational Site 12112, Mobile, Alabama, United States
Teva Investigational Site 12130, Pell City, Alabama, United States
Teva Investigational Site 12119, Little Rock, Alaska, United States
Teva Investigational Site 12076, Phoenix, Arizona, United States
Teva Investigational Site 12135, Scottsdale, Arizona, United States
Teva Investigational Site 12132, Tucson, Arizona, United States
Teva Investigational Site 12102, Fountain Valley, California, United States
Teva Investigational Site 12104, Fresno, California, United States
Teva Investigational Site 12123, Fullerton, California, United States
Teva Investigational Site 12103, Huntington Beach, California, United States
Teva Investigational Site 12073, Long Beach, California, United States
Teva Investigational Site 12077, Mission Viejo, California, United States
Teva Investigational Site 12098, Napa, California, United States
Teva Investigational Site 12149, Northridge, California, United States
Teva Investigational Site 12081, Orange, California, United States
Teva Investigational Site 12100, Rancho Mirage, California, United States
Teva Investigational Site 12133, Riverside, California, United States
Teva Investigational Site 12146, Riverside, California, United States
Teva Investigational Site 12075, Rolling Hills Estates, California, United States
Teva Investigational Site 12074, San Diego, California, United States
Teva Investigational Site 12150, San Diego, California, United States
Teva Investigational Site 12064, San Jose, California, United States
Teva Investigational Site 12061, Stockton, California, United States
Teva Investigational Site 12141, Walnut Creek, California, United States
Teva Investigational Site 12043, Denver, Colorado, United States
Teva Investigational Site 12051, Denver, Colorado, United States
Teva Investigational Site 12091, Waterbury, Connecticut, United States
Teva Investigational Site 12078, Fort Lauderdale, Florida, United States
Teva Investigational Site 12140, Hialeah, Florida, United States
Teva Investigational Site 12066, Kissimee, Florida, United States
Teva Investigational Site 12120, Miami, Florida, United States
Teva Investigational Site 12127, Miami, Florida, United States
Teva Investigational Site 12148, Miami, Florida, United States
Teva Investigational Site 12114, Ocala, Florida, United States
Teva Investigational Site 12055, Sarasota, Florida, United States
Teva Investigational Site 12048, Tallahassee, Florida, United States
Teva Investigational Site 12122, Tamarac, Florida, United States
Teva Investigational Site 12086, Winter Park, Florida, United States
Teva Investigational Site 12111, Gainesville, Georgia, United States
Teva Investigational Site 12070, Lawrenceville, Georgia, United States
Teva Investigational Site 12072, Marietta, Georgia, United States
Teva Investigational Site 12106, Coeur d'Alene, Idaho, United States
Teva Investigational Site 12117, Eagle, Idaho, United States
Teva Investigational Site 12065, River Forest, Illinois, United States
Teva Investigational Site 12059, Shiloh, Illinois, United States
Teva Investigational Site 12056, Overland Park, Kansas, United States
Teva Investigational Site 12138, Fort Mitchell, Kentucky, United States
Teva Investigational Site 12092, Owensboro, Kentucky, United States
Teva Investigational Site 12087, Covington, Louisiana, United States
Teva Investigational Site 12095, Bangor, Maine, United States
Teva Investigational Site 12042, Baltimore, Maryland, United States
Teva Investigational Site 12124, Baltimore, Maryland, United States
Teva Investigational Site 12052, North Dartmouth, Massachusetts, United States
Teva Investigational Site 12139, Minneapolis, Minnesota, United States
Teva Investigational Site 12137, Plymouth, Minnesota, United States
Teva Investigational Site 12079, Columbia, Missouri, United States
Teva Investigational Site 12067, Rolla, Missouri, United States
Teva Investigational Site 12060, Saint Louis, Missouri, United States
Teva Investigational Site 12108, St Louis, Missouri, United States
Teva Investigational Site 12057, St. Louis, Missouri, United States
Teva Investigational Site 12128, Warrensberg, Missouri, United States
Teva Investigational Site 12136, Bellevue, Nebraska, United States
Teva Investigational Site 12115, Las Vegas, Nevada, United States
Teva Investigational Site 12131, Las Vegas, Nevada, United States
Teva Investigational Site 12126, Ocean, New Jersey, United States
Teva Investigational Site 12129, Verona, New Jersey, United States
Teva Investigational Site 12058, Rochester, New York, United States
Teva Investigational Site 12113, Rockville Centre, New York, United States
Teva Investigational Site 12047, Charlotte, North Carolina, United States
Teva Investigational Site 12085, Charlotte, North Carolina, United States
Teva Investigational Site 12144, Winston-Salem, North Carolina, United States
Teva Investigational Site 12053, Canton, Ohio, United States
Teva Investigational Site 12094, Cincinnati, Ohio, United States
Teva Investigational Site 12105, Cincinnati, Ohio, United States
Teva Investigational Site 12107, Sylvania, Ohio, United States
Teva Investigational Site 12069, Tiffin, Ohio, United States
Teva Investigational Site 12045, Oklahoma City, Oklahoma, United States
Teva Investigational Site 12080, Oklahoma City, Oklahoma, United States
Teva Investigational Site 12083, Oklahoma City, Oklahoma, United States
Teva Investigational Site 12062, Eugene, Oregon, United States
Teva Investigational Site 12097, Medford, Oregon, United States
Teva Investigational Site 12049, Portland, Oregon, United States
Teva Investigational Site 12134, Bryn Mawr, Pennsylvania, United States
Teva Investigational Site 12090, Philadelphia, Pennsylvania, United States
Teva Investigational Site 12089, Providence, Rhode Island, United States
Teva Investigational Site 12088, Warwick, Rhode Island, United States
Teva Investigational Site 12096, Charleston, South Carolina, United States
Teva Investigational Site 12147, Spartanburg, South Carolina, United States
Teva Investigational Site 12121, Dallas, Texas, United States
Teva Investigational Site 12110, Duncanville, Texas, United States
Teva Investigational Site 12099, El Paso, Texas, United States
Teva Investigational Site 12071, Live Oak, Texas, United States
Teva Investigational Site 12054, San Antonio, Texas, United States
Teva Investigational Site 12145, Waco, Texas, United States
Teva Investigational Site 12046, Murray, Utah, United States
Teva Investigational Site 12041, South Burlington, Vermont, United States
Teva Investigational Site 12125, Richmond, Virginia, United States
Teva Investigational Site 12101, Seattle, Washington, United States
Teva Investigational Site 12109, Spokane, Washington, United States
Teva Investigational Site 12044, Tacoma, Washington, United States
Teva Investigational Site 12082, Greenfield, Wisconsin, United States